62
For Medical Students For Medical Students

General Nuclear Medicine Part 2

Embed Size (px)

DESCRIPTION

 

Citation preview

Page 1: General Nuclear Medicine Part 2

For Medical StudentsFor Medical Students

Page 2: General Nuclear Medicine Part 2

J SRIPRAPAPORN

Liver scanHepatobiliary scintigraphyGI Tract• GI bleeding study• Meckel’s diverticulum• Gastroesophageal studiesBrain scanNuclear cardiology

Page 3: General Nuclear Medicine Part 2

J SRIPRAPAPORN

The biggest organ, 1500 gAnatomy: 4 parts- Right, Left, Caudate, and Quadrate lobesHistology:

Hepatocytes or polygonal cellsRE cells (Kupffer’s cells)

phagocytosisBlood Supply:

Portal vein 75 %Hepatic artery 25 %

THE LIVER

Page 4: General Nuclear Medicine Part 2

J SRIPRAPAPORN

Tracer: 99mTc-sulfer colloid/ phytateRoute : IV injectionMechanism : Phagocytosis by RE cells (liver,spl,BM)Visualization : Liver and SpleenTechnique:

Patient preparation : noneImaging : 15-20 min. Pi.Static 6 views ; Ant, Post, RL, LL, RAO, LAOSPECT images

Diagnosis : Diffuse & focal lesions focal defect(s) -nonspecific (abscess, metastasis, cyst etc.)

LIVER-SPLEEN SCAN(Routine Liver Scan)

Page 5: General Nuclear Medicine Part 2

J SRIPRAPAPORN

Normal Liver Scan Abnormal Liver Scan:Multiple focal defects

LIVER-SPLEEN SCAN

Page 6: General Nuclear Medicine Part 2

J SRIPRAPAPORN

Tc-99m RBC LIVER SCAN

Aim: hepatic hemangioma [hemangioma is the most common benign liver tumor ]U/S: Typical hyperechoic mass in 60%CT scan: Classical findings in 50-75%MRI has an accuracy of between 90-95%Tc-RBC imaging is the most specific test for Dxcavernous hemangioma. (Sens 90% for lesions >1.5-2 cm; Spec approaches 100%; Acc 90-95%).With SPECT lesions down to about 1 cm in size can be detected [SPECT sensitivity by size: 1.5 cm (100%), 1 cm (65%), 0.5 cm (20%)].

Ref: www.auntminnie.com

Page 7: General Nuclear Medicine Part 2

J SRIPRAPAPORN

Vascular Study SPECT

HEPATIC HEMANGIOMA

Imaging: Flow, Static, Delayed***Positive : activity with time hot lesion

3-D image

Page 8: General Nuclear Medicine Part 2

J SRIPRAPAPORN

Liver scanHepatobiliary scintigraphyGI Tract• GI bleeding study• Meckel’s diverticulum• Gastroesophageal studiesBrain scanNuclear cardiology

Page 9: General Nuclear Medicine Part 2

J SRIPRAPAPORN

HEPATOBILIARY IMAGING

Page 10: General Nuclear Medicine Part 2

J SRIPRAPAPORN

Tracers : 99mTc-IDA derivatives (Tc-99m DISIDA, Mebrofenin)Route : IV injectionMechnism : Carrier-mediated, non sodium dependent organic anion transport processTechnique : - Fasting 4-6 hr

- Dynamic study for at least 1 hour +/-delayed imaging

Visualization : Liver and biliary system including gallbladder until excretion into small bowel (normal = within 1 hour)

HEPATOBILIARY IMAGING

Page 11: General Nuclear Medicine Part 2

J SRIPRAPAPORN

Gallbladder disease :Acute cholecystitis*

• Non-visualization of the GB after 4 hrs

• sen > 95% , spec > 98%Biliary tract obstruction

DDx biliary atresia vsneonatal hepatitis

Biliary leakage

HEPATOBILIARY IMAGING: INDICATIONS

Page 12: General Nuclear Medicine Part 2

J SRIPRAPAPORN

Tc-99m DISIDA

Visualization :Liver and biliary system including

Right & left hepatic ductsCommon hepatic ductCommon bile ductGallbladder Until excreted into small bowel

Within 1 hour

NORMAL HEPATOBILIARY IMAGING

Page 13: General Nuclear Medicine Part 2

J SRIPRAPAPORN

DISIDA Scan-Dynamic Study

Page 14: General Nuclear Medicine Part 2

J SRIPRAPAPORN

Is it normal study ?

Acute cholecytitisNo visualization of GB

Page 15: General Nuclear Medicine Part 2

J SRIPRAPAPORN

Acute cholecystitisSevere chronic cholecystitisProlonged fastingIntercurrent severe illnessAcute pancreatitisSevere liver diseaseS/P cholecystectomy

DDx Nonvisualized GB

Ac chole wo gallstone !

Page 16: General Nuclear Medicine Part 2

J SRIPRAPAPORN

False-negative Test

It is found less than 5% of patients, and may be associated with:Incomplete cystic duct obstruction Acalculous cholecystitisAccessory cystic duct Duodenal diverticulum simulating GB activity

Page 17: General Nuclear Medicine Part 2

J SRIPRAPAPORN

DDx biliary atresia & neonatal jaundiceSen 97-100%, spec 82-94%, and accuracy of 91%Findings of BA:

Good hepatic uptakeNo visualization of GBNon-visualization of the biliary tree and bowel

Findings of neonatal hepatitisVariable hepatic uptake // Fn.Visualization of GBPresence of radioactivity excretion into small bowel

NEONATAL JAUNDICE

Page 18: General Nuclear Medicine Part 2

J SRIPRAPAPORNEarly images 24-hr image

BILIARY ATRESIA

Page 19: General Nuclear Medicine Part 2

J SRIPRAPAPORN

HB Scintigraphy in BA

Normal uptake and excretion of the tracer in a jaundiced neonate excludes the diagnosis of biliary atresia.Children should be studied before age of 3 months Beyond 3 months of age, the prolonged obstruction will begin to affect liver function and hepatic extraction of the tracer will deteriorate making differentiation from hepatitis more difficult.

Page 20: General Nuclear Medicine Part 2

J SRIPRAPAPORN

Liver scanHepatobiliary scintigraphyGI Tract• GI bleeding study• Meckel’s diverticulum• Gastroesophageal studiesBrain scanNuclear cardiology

Page 21: General Nuclear Medicine Part 2

J SRIPRAPAPORN

GI BLEEDING STUDYBleeding from lower GI tractActive bleeding is necessary for positive imaging.Preparation: NPOPosition: Supine- anterior abdomenTc99m-SC or Tc99m-RBC* (intermittent)Imaging:

Flow 1 minDynamic imaging for 1-2 hr with additional delayed images as required.

Page 22: General Nuclear Medicine Part 2

J SRIPRAPAPORN

Extravasation of the tracer into bowel lumenFocal area of increased activity, move // bowel movement

Pattern depends on site of bleeding & bowel peristalsis

•Tc-99m RBC

•Hepatic flexure

GI BLEEDING

Page 23: General Nuclear Medicine Part 2

J SRIPRAPAPORN

GI BLEEDING

ST, Date: 4-6-07GIV002-07

SA-ING THONGKAM

CINE MODE

Page 24: General Nuclear Medicine Part 2

J SRIPRAPAPORN

More sensitiveLess specificLess anatomical detailsLess invasiveLower riskSimpler

Less sensitiveMore specific-causeBetter anatomical detailsMore invasiveHigher riskNeeds more skills

Tc-99m RBC Scan vs Angiography

Page 25: General Nuclear Medicine Part 2

J SRIPRAPAPORN

Remnant of omphalomesenteric ductGastric mucosal lining*Common cause of lower GI bleeding in small childrenImaging:

Principal: Localization of ectopic gastric mucosaPatient preparation: NPO 4 hrRadiopharm: Tc-99m pertechnetate IV.Sequential imaging for 1-2 hr.Positive findings: Focal hot spot (RLQ) // stomach activitySen 85%, spec 95%

MECKEL’S DIVERTICULUM

Page 26: General Nuclear Medicine Part 2

J SRIPRAPAPORN

MECKEL’S DIVERTICULUM

Bladder

Stomach

M

Stomach

U. Bladder

Page 27: General Nuclear Medicine Part 2

J SRIPRAPAPORN

GASTRO-ESOPHAGEAL STUDY

Esophageal transit study

Gastroesophageal reflux study (milk scan)

Gastric emptying study

Page 28: General Nuclear Medicine Part 2

J SRIPRAPAPORN

Indication: To detect GE reflux:-regurgitation of gastric contents esophagusTracers : Tc-99m phytate, Tc-99m SC 300 uCiTechnique :

NPO, oral tracer adm. within 30 sSupine imaging over EG junctionDynamic imaging for >10-20min. Views: anterior ( & posterior)

Positive : Activity from the stomach esophagus [N < 3 %, Abn >4 %]

GE REFLUX STUDY(MILK SCAN)

Page 29: General Nuclear Medicine Part 2

J SRIPRAPAPORN

GE Reflux (Milk Scan)Rdn study provides higher sensitivity but less anatomical details than esophagogramSensitivity and specificity for detecting GER are 75%-100% and 93%.

Ref: J Nucl Med 2004; Mariani G, et al. Radionuclide gastroesophageal motor studies. 45: 1004-1028

Ravelli, A. M. et al. Chest 2006;130:1520-1526

Page 30: General Nuclear Medicine Part 2

J SRIPRAPAPORN

Liver scanHepatobiliary scintigraphyGI Tract• GI bleeding study• Meckel’s diverticulum• Gastroesophageal studiesBrain scanNuclear cardiology

Page 31: General Nuclear Medicine Part 2

J SRIPRAPAPORN

1. Conventional Rdn. brain imaging

Tracers: Tc- 99m pertechnetate, Tc-99m DTPA*, Tc-99m glucoheptonateHydrophilic tracers:cannot pass normal BBB.(Normally no tracer accumulation in the brain tissue)Disrupted BBB abnormal uptake

2. Cerebral perfusion SPECT

Radiopharm.: I-123 IMP ,Tc-99m HMPAO*, Tc-99m ECDLipophilic tracers, can pass intact BBB.Uptake: proportion to regional cerebral blood flowIndications: CVD,epilepsy, dementias,parkinsonism, ect.

BRAIN IMAGING

Page 32: General Nuclear Medicine Part 2

J SRIPRAPAPORN

Picker-Prism

SPECT BRAIN IMAGING

Page 33: General Nuclear Medicine Part 2

J SRIPRAPAPORN

Brain death: Tc-99m DTPA, Tc-99m HMPAO, TC-99M ECD

Cerebrovascular diseaseFocal seizureDementiaPsychitric disordersOthers

APPLICATIONS

Page 34: General Nuclear Medicine Part 2

J SRIPRAPAPORN

www.derriford.co.uk/nucmed

NORMAL BRAIN SPECT

Page 35: General Nuclear Medicine Part 2

J SRIPRAPAPORN

Flow study : no appreciable intracerebral blood flow in either the internal carotid or posterior cerebral circulations.Planar static images: “Hot nose” sign due to shunting of flow from int carotid to ext carotid system, which supplies face & scalp.Tc-99m HMPAO SPECT: No cerebral uptake

Www.cseserv.engr.scu.edu/StudentWebPages/DZepeda/brainscin.html

BRAIN DEATH

Page 36: General Nuclear Medicine Part 2

J SRIPRAPAPORN

SPECT

Static

FlowTc-99m HMPAO

BRAIN DEATH

Page 37: General Nuclear Medicine Part 2

J SRIPRAPAPORN

Stroke at left temporoparietal region

www.derriford.co.uk/nucmed

3D

STROKE

Page 38: General Nuclear Medicine Part 2

J SRIPRAPAPORNwww.derriford.co.uk/nucmed

FOCAL SEIZURE

Page 39: General Nuclear Medicine Part 2

J SRIPRAPAPORN

SPECT

www.derriford.co.uk/nucmed

ALZHIEMER’S DISEASE

Decreased perfusion at bilateral parieto-temporal regions

Page 40: General Nuclear Medicine Part 2

J SRIPRAPAPORN

PET

ALZHIEMER’S DISEASE

Page 41: General Nuclear Medicine Part 2

J SRIPRAPAPORN

A labeled amino acid called F-DOPA is used with PET to see if your brain has a deficiency in dopamine synthesis.

Striatral uptake PET

PARKINSON DISEASE

Page 42: General Nuclear Medicine Part 2

J SRIPRAPAPORN

Liver scanHepatobiliary scintigraphyGI Tract• GI bleeding study• Meckel’s diverticulum• Gastroesophageal studiesBrain scanNuclear cardiology

Page 43: General Nuclear Medicine Part 2

J SRIPRAPAPORN

NUCLEAR CARDIOLOGY

Radionuclide angiocardiography *

Equilibrium gated blood pool study (GBP or MUGA study)*

Myocardial infarct imaging

Myocardial perfusion imaging**

Page 44: General Nuclear Medicine Part 2

J SRIPRAPAPORN

RADIONUCLIDE ANGIOCARDIOGRAPHY

First pass Rdn. angiocardiography

Equilibrium gated blood pool study (MUGA study)**

Page 45: General Nuclear Medicine Part 2

J SRIPRAPAPORN

FIRST PASS RDN.VENTRICULOGRAPHY

Tracers: Tc-99m agentsIndications:

Diagnosis of SVC obstruction (first pass)Calculation of ejection fraction: RVEF, LVEF

• EF = (ED-ES)/ED

Page 46: General Nuclear Medicine Part 2

J SRIPRAPAPORN

Equilibrium MUGA

Tracer: Tc-99m RBCFindings

Cardiac shape and sizeWall motion*: global, regionalStroke volume (ED counts - ES counts)Ejection fraction (EF): LV, RV

• EF = (ED counts - ES counts) / (ED counts)• Normal LVEF is typically 60-70%. (LVEF < 50% is definitely abnormal

• RVEF should > 41%.

Page 47: General Nuclear Medicine Part 2

J SRIPRAPAPORN

Equilibrium MUGA

Findings (cont.)LV outputs

• Phase analysis: dyskinesis eg. aneurysm• Amplitude analysis

Diastolic ventricular functionIndications

DDx CAD from cardiomyopathyPlan Rx valvular heart diseaseMonitoring cardiac toxicity from chemotherapeutic agent eg. adriamycin

Page 48: General Nuclear Medicine Part 2

J SRIPRAPAPORN

Equilibrium MUGA

Page 49: General Nuclear Medicine Part 2

J SRIPRAPAPORN

Page 50: General Nuclear Medicine Part 2

J SRIPRAPAPORN

MYOCARDIAL INFARCT IMAGING

Tracer: Tc-99m pyrophosphate (PYP)Mechanism: Bind to calcium in AMI Indication:

Dx AMI

Page 51: General Nuclear Medicine Part 2

J SRIPRAPAPORN

MYOCARDIAL PERFUSION IMAGING

Tracers:Thallium-201 (Tl-201)Tc-99m MIBI (Cardiolyte)Tc-99m tetrofosmin

Principle: Myocardial perfusion of LV*Technique

Acquire rest & stress imagesStress: exercise or pharmacological tests

Page 52: General Nuclear Medicine Part 2

J SRIPRAPAPORN

EXERCISE STRESS TEST

Page 53: General Nuclear Medicine Part 2

J SRIPRAPAPORN

PHARMACOLOGICAL STRESS TEST

Dipyridamole (Persantin)

Dobutamine

Adenosine

Page 54: General Nuclear Medicine Part 2

J SRIPRAPAPORN

MYOCARDIAL PERFUSION IMAGING

Imaging techniquesPlanar images: 2DSPECT images*: 3D

• short axis,• long axis-LH, LV

Gated SPECT: contractile function (LVEF)Interpretation

Compare between rest & stress images• Fixed perfusion defect: infarct• Transient perfusion defect: ischemia

Page 55: General Nuclear Medicine Part 2

J SRIPRAPAPORN

Heart Orientation & Heart Plane

Page 56: General Nuclear Medicine Part 2

J SRIPRAPAPORN

Planes & SPECT Images

LAT

SEP

Page 57: General Nuclear Medicine Part 2

J SRIPRAPAPORN

MYOCARDIAL PERFUSION IMAGING:INDICATIONS

Screening - preoperative evaluationDetection of CADEvaluation of extent & severityAssess myocardial viabilityPlan of Rx: revascularization vs medical RxPost MI evaluationPrognosis of CAD patients Assess outcome & efficacy of Rx (F/U)Dx restenosis after revascularization

Page 58: General Nuclear Medicine Part 2

J SRIPRAPAPORN

Normal Tc-99m MIBI MPI

STRESS

REST

STRESS

REST

SHORT AXIS

LONG HORIZONTAL AXIS

Page 59: General Nuclear Medicine Part 2

J SRIPRAPAPORN

Normal Myocardial Perfusion Scintigraphy

Polar Map

Bull’s Eye

Page 60: General Nuclear Medicine Part 2

J SRIPRAPAPORN

Fixed Defect:Inferolateral Wall MI

Page 61: General Nuclear Medicine Part 2

J SRIPRAPAPORN

Reversible Defect: Anteroseptal Wall Ischemia

Page 62: General Nuclear Medicine Part 2

J SRIPRAPAPORN

MPI: Summary

Myocardial perfusion study is an noninvasive nuclear medicine study that evaluate regional myocardial perfusion as well as LV contraction-EF and regional wall motion in a single setting.